3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
6
Other neoplasm
1
Gastrointestinal
1
Conditions
Precancerous Conditions
36
Uterine Cervical Neoplasms
8
Uterine Cervical Dysplasia
7
Obesity-Related Malignant Neoplasm
6
Neoplasms
6
Advanced Malignant Neoplasm
6
Leukemia, Lymphocytic, Chronic, B-Cell
5
Multiple Myeloma
4
Leukemia
4
Colorectal Neoplasms
4
Cancer-related Problem/Condition
4
Waldenstrom Macroglobulinemia
3
Thrombocythemia, Essential
3
Stomach Neoplasms
3
Sezary Syndrome
3
Primary Myelofibrosis
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Polycythemia Vera
3
Pdgfra-Associated Chronic Eosinophilic Leukemia
3
Neoplasms, Plasma Cell
3
Myeloproliferative Disorders
3
Myelodysplastic-Myeloproliferative Diseases
3
Myelodysplastic Syndromes
3
Mycosis Fungoides
3
Multiple Chronic Conditions
3
Monoclonal Gammopathy of Undetermined Significance
3
Malignant Neoplasms of Independent (Primary) Multiple Sites
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, Non-Hodgkin
3
Interventions
Robotic Surgical Procedures
1
Hysterectomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Adenomyosis
×
Other neoplasm
×
Clear all
NCT07120945
2026-06-02
Embrace Gyn
Medtronic - MITG
Phase NA
Active not recruiting
70 enrolled